Bfsg, LLC Gsk PLC Transaction History

Bfsg, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$36.52 - $41.46 $1.29 Million - $1.47 Million	-35,352 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$34.27 - $40.01 $70,253 - $82,020	-2,050 Reduced 5.48%	35,352 $1.26 Million
Q4 2020 Jan 26, 2021	SELL	$34.07 - $39.94 $24,325 - $28,517	-714 Reduced 1.87%	37,402 $1.38 Million
Q3 2020 Nov 04, 2020	SELL	$38.11 - $42.99 $1,524 - $1,719	-40 Reduced 0.1%	38,116 $1.44 Million
Q1 2020 Apr 27, 2020	SELL	$32.47 - $48.83 $56,335 - $84,720	-1,735 Reduced 4.35%	38,156 $1.45 Million
Q4 2019 Jan 29, 2020	SELL	$42.0 - $48.25 $4,200 - $4,825	-100 Reduced 0.25%	39,891 $1.87 Million
Q3 2019 Oct 25, 2019	BUY	$40.46 - $43.52 $1.62 Million - $1.74 Million	39,991 New	39,991 $1.65 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

Stay updated on Bfsg, LLC with notifications on news.